SEP 24, 2014 9:00 AM PDT

The therapeutic discovery landscape: revolution and evolution

Speaker
  • Senior Vice President of Research, Amgen
    Biography
       Alexander Kamb received his A.B. from Harvard University and his Ph.D. from Caltech.  After a postdoctoral fellowship at UCSF, he worked in the biotechnology field for about ten years, specializing in the genetics of cancer, and then in the Pharmaceutical sector where he led the Novartis Oncology Research Group.  In 2006, Dr. Kamb joined Amgen to direct Oncology Research at their South San Francisco site.  In 2007 he took over the leadership of the Neurosciences Therapeutic Area. In February 2010 he was promoted to Vice President, Research, Neuroscience, and was given the remit to build a specialized department within Amgen Research (Genome Analysis Unit) focused on cross-disease-area applications of next-generation sequencing.  At the end of 2011, Dr. Kamb was promoted to Senior Vice President to head all of Amgens discovery research.

    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    SEP 03, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 03, 2020 9:00 AM PDT
    DATE: September 3, 2020 TIME: 09:00am PT, 12:00pm ET xxx Learning Objectives: xxx Webinars will be available for unlimited on-demand viewing after live event. LabRoots is approved as a provi...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    C.E. CREDITS
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    Loading Comments...
    Show Resources